Cargando…
Modified mRNA Therapeutics for Heart Diseases
Cardiovascular diseases (CVD) remain a substantial global health problem and the leading cause of death worldwide. Although many conventional small-molecule treatments are available to support the cardiac function of the patient with CVD, they are not effective as a cure. Among potential targets for...
Autor principal: | Magadum, Ajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779737/ https://www.ncbi.nlm.nih.gov/pubmed/36555159 http://dx.doi.org/10.3390/ijms232415514 |
Ejemplares similares
-
mRNA-Based Protein Replacement Therapy for the Heart
por: Magadum, Ajit, et al.
Publicado: (2019) -
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
por: Magadum, Ajit, et al.
Publicado: (2021) -
Modified mRNA as a Therapeutic Tool for the Heart
por: Kaur, Keerat, et al.
Publicado: (2020) -
Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury
por: Sultana, Nishat, et al.
Publicado: (2020) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)